Page last updated: 2024-08-26

u 69593 and Dyskinesia Syndromes

u 69593 has been researched along with Dyskinesia Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Faden, AI; Fernyak, S; McIntosh, TK; Yamakami, I	1

Other Studies

1 other study(ies) available for u 69593 and Dyskinesia Syndromes

Article	Year
Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats. The American journal of physiology, 1994, Volume: 267, Issue:3 Pt 2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Behavior, Animal; Benzeneacetamides; Brain; Brain Injuries; Cardiovascular System; Dynorphins; Injections, Intravenous; Injections, Intraventricular; Male; Movement Disorders; Nervous System; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Survival Analysis	1994

Article

Year

Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats.

The American journal of physiology, 1994, Volume: 267, Issue:3 Pt 2

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Behavior, Animal; Benzeneacetamides; Brain; Brain Injuries; Cardiovascular System; Dynorphins; Injections, Intravenous; Injections, Intraventricular; Male; Movement Disorders; Nervous System; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Survival Analysis

1994